Pioneering Biotech Company Athos Deploys NVIDIA HGX H100 GPUs on Vultr

Athos Therapeutics, Inc., a clinical-stage biotechnology company specializing in precision small molecule therapeutics for immune-mediated diseases and cancer, is leveraging NVIDIA HGX H100 GPUs on Vultr's cloud platform to revolutionize their AI-driven research. Through a partnership with Dell Technologies, Athos transitioned from traditional public cloud providers to Vultr, addressing issues of cost, scalability, and engineering support while enhancing their AI capabilities. This move has enabled Athos to manage and analyze growing datasets essential for developing precision medicine and advancing drug discovery. The collaboration underscores the importance of robust and adaptable cloud solutions in supporting cutting-edge biotech research, with Athos committed to delivering innovative therapeutics for patients.

No tracked trend matches for this post yet.

Use this post, company, and trend context to find content marketing opportunities, perform competitive analysis, or address product feature gaps via the Plushcap MCP server or the Plushcap API.